Skip to content
Wenlo
Sign in
← Markets

BioLineRx Ltd.

BioLineRx Ltd. (BLRX) — Form SCHEDULE 13G: Ownership over 5% (passive)

SC 13GBLRXFiled Nov 16, 2026, 7:03 AM ET

About this filing

BioLineRx Ltd. (BLRX) filed Form SCHEDULE 13G (ownership over 5% (passive)) with the SEC on Nov 16, 2026. A Schedule 13G reports a passive investor owning more than 5% of the company.

Key facts

Document
—

More BLRX filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.